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Patients without diabetic retinopathy (DR) represent a large proportion of the caseload seen by the DR screening service so
reliable recognition of the absence of DR in digital fundus images (DFIs) is a prime focus of automated DR screening research.
We investigate the use of a novel automated DR detection algorithm to assess retinal DFIs for absence of DR. A retrospective,
masked, and controlled image-based study was undertaken. 17,850 DFIs of patients from six different countries were assessed
for DR by the automated system and by human graders. The system’s performance was compared across DFIs from the different
countries/racial groups.The sensitivities for detection of DR by the automated system were Kenya 92.8%, Botswana 90.1%, Norway
93.5%,Mongolia 91.3%, China 91.9%, and UK 90.1%.The specificities were Kenya 82.7%, Botswana 83.2%, Norway 81.3%,Mongolia
82.5%, China 83.0%, and UK 79%. There was little variability in the calculated sensitivities and specificities across the six different
countries involved in the study.These data suggest the possible scalability of an automated DR detection platform that enables rapid
identification of patients without DR across a wide range of races.
1. Introduction
Patients without diabetic retinopathy (DR) represent a large
proportion of the caseload seen by the DR screening service
and can be time consuming to identify for human graders [1].
Microaneurysms (MAs) are the first visible sign of DR and
their detection has been widely described in the literature as
an important factor in identifying the onset of DR [2, 3]. As
such, reliable recognition of the absence of microaneurysms
initially on FFA [4] and subsequently in digital fundus images
[5] (DFIs) has been a prime focus of automated DR screening
research for many years.
DR detection is partly undertaken through contrast of the
MAwith the background field of the DFIs.The appearance of
the background field in DFIs is highly variable and is influ-
enced by many factors including the degree of pigmentation
in the retinal pigment epithelium and choroid, the size of the
pupil, unevenness in illumination, poor transparency of the
ocular media in corneal disease and cataract, and the camera
type and its settings [6]. Variability in the background field
is further complicated by well-reported racial variance, for
example, in the calibre of retinal blood vessels [7–9].
The effect of differing racial and image influences have not
previously been evaluated in the domain of DR identification
Hindawi Publishing Corporation
Journal of Ophthalmology
Volume 2016, Article ID 4176547, 5 pages
http://dx.doi.org/10.1155/2016/4176547
2 Journal of Ophthalmology
Table 1: Prevalence of microaneurysms within each studied image
dataset as determined by human graders.
Prevalence of microaneurysms as
detected by human graders
Kenya 9.2%
Botswana 30.4%
Norway 9.6%
Mongolia 11.3%
China 8.2%
UK 11.7%
using automated screening algorithms. As the racial variance
in pigmentation is known to influence the background field
that automated systems use to operate it is important to
know whether this will influence their performance of this
important detection task [10]. Better defining these potential
effects will be central to the future functionality and clinical
usefulness of these platforms.
The aim of this study is to investigate the use of an
automated DR detection algorithm to assess retinal DFIs and
to evaluate its performance across patients of different racial
backgrounds relative to a human observer.
2. Materials and Methods
Thiswas a retrospective,masked, and controlled image-based
study. Full Institutional Review Board approval was obtained
for this study. The retrospective use of anonymized retinal
images from data banks did not require ethics approval.
2.1. Subjects. A dataset from Moorfields Eye Hospital of
digital fundal images of patients from six different countries
and of varying race was retrospectively identified. In total
17,850 digital fundus images from population studies in six
different countries were identified. The number of images
from each country was Kenya 12,587, Botswana 500, Norway
840, Mongolia 1636, China 1079, and UK 1208. The images
from Kenya and Norway originate from population screen-
ing, while those from Botswana andMongolia originate from
DR screening. The images from the UK and China originate
from patients attending ophthalmic clinics: in the case of
the UK, all patients had diabetes. All patients were aged 18
or over. In all cases patients were almost exclusively of the
racial group that predominates in the relevant country as
follows: Kenya and Botswana: African; Norway and the UK:
Caucasian; China: Chinese; and Mongolia: Mongolian.
The prevalence of microaneurysms in the images as
determined by human graders (the current gold standard)
was as shown in Table 1.
These images were presented to the automated system
described below in order to identify the eyes that did not have
any evidence of microaneurysms.
2.2. Digital Fundus Photographs. One fovea centred digital
fundus photograph was taken of each eye. The present study
examined the fovea centred images. The resolution of the
images varied from 3888 × 2592 pixels in Mongolia to 768
× 576 pixels in the UK.
2.3.TheDaphneAutomatedMicroaneurysmDetection System.
The Daphne automated microaneurysm detection system
assesses digital fundus images in order to detect microa-
neurysms. It is a noncommercialised software package newly
developed in theDepartment of Computer Sciencewithin the
Faculty of Engineering and Physical Science at the University
of Surrey [11]. The aim of the system is to detect microa-
neurysms with high sensitivity, thus allowing any images
where no microaneurysms are detected to be considered free
of DR.
2.3.1. System Development. The automated system was built
to detect microaneurysms in a three-stage process as
described below. The system was then calibrated by pre-
senting it with 50 digital fundus photographs from the
retinopathy online challenge (ROC). Each image had already
been graded by humans allowing feedback on the system’s
performance.The results from the 50 training cases were used
to fine-tune the system’s parameters. The system was then
tested using unseen retinal photographs from the datasets
described above.
2.3.2. Technical Specifications. Theprocessing time per image
on a computer equipped with an Intel Core i5 processor
running at 2.2 GHz was one minute. The method is currently
implemented usingMATLAB.This software is currently only
available for research.
2.3.3. Three-Stage Process of Microaneurysm Detection
(1) Image Preprocessing. Images are assessed for quality and
those that do not meet the required quality standard are
excluded from further analysis. Image quality is acceptable
if the retinal vasculature could be visualised and they were
correctly centred on the disc or fovea as appropriate. Images
of varying resolutions are then automatically resized and
cropped to a standard size and resolution.
Colour digital fundus photographs meeting the quality
criteria are passed through a red-free filter in order to render
microaneurysms and other vascular features as dark lesions.
A Gaussian filter is then applied to the red-free image in
order to enhance small and dark structures, which include
microaneurysms. Bright lesions (such as cotton wool spots
and exudates) are removed from the image using a shade
correction algorithm [12] in order to prevent small darker
gaps between two adjacent bright lesions being confused for
a microaneurysm.
(2) Extraction of All Potential Microaneurysm Candidate
Lesions. All lesions in the preprocessed photograph that are
possible microaneurysms are detected. This is achieved by
passing the image through amultilayered dark object filtering
method [11, 13] which was set to search for dark lesions
approximately seven pixels in diameter. This step has a high
sensitivity but low specificity for microaneurysms.
(3) Selection of True Microaneurysms from Candidate Pool.
The pool of candidate lesions (possible microaneurysms) is
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Figure 1: SSA cross-section profiles of different objects. (a)MA, (b) blood vessels crossing, (c) haemorrhage (an elongated non-MA structure),
and (d) a retinal background. The white circles in the middle of the images indicate the actual cross-section scanning regions with 31-pixel
diameter.
further processed to separate the true positives from the
false positives. The candidate lesions are analysed using
singular spectrum analysis (SSA) [14]. SSA involves pro-
filing the intensity of the candidates by generating several
cross-sectional profiles through the candidate in different
orientations. Microaneurysms tend to differ from other dark
lesions such as haemorrhages or small blood vessels in that
they display a high level of rotational symmetry. Therefore,
a candidate was determined to be a microaneurysm when
there was a high level of similarity between all cross-sectional
intensity profiles at all orientations. This is demonstrated
graphically in Figure 1.
2.4. Classification of the Images by Trained Human Graders.
A human grader classified the fundus photographs into two
groups based on the presence or absence of DR according to
theUKnational screening guidelines for diabetic retinopathy.
A second human grader reclassified a minimum of 10% of
randomly selected images for quality control. Human graders
were based at the Reading Centre at Moorfields Eye Hospital,
London, UK, and at the Department of Computer Science,
University of Surrey, UK. All human graders had undergone
standard training as required to be a grader for the UK’s DR
screening programme.
In cases where there was disagreement between machine
and human grading, a senior human grader decided the
appropriate grading.
2.5. Statistical Analysis. The sensitivity and specificity of the
automated system’s ability to detect DR were analysed for
each of the populations studied, taking the human graders’
results as the gold standard. The sensitivity and specificity
values and their standard deviations across different races
were analysed usingR Studio software, R consortium, Boston,
MA, USA [15]. Standardised positive and negative predictive
values of the automated system were also calculated for each
country based on the known prevalence of DR amongst
patients with diabetes within the relevant racial group, as
reported by Yau et al. 2012 [16]: 27% for China andMongolia,
56% for Kenya and Botswana, and 47% for Norway and the
UK.
3. Results
The sensitivities, defined as the proportion of patients classi-
fied as having microaneurysms by human graders that were
correctly identified by the automated system, were as follows:
Kenya 92.8%, Botswana 90.1%, Norway 93.5%, Mongolia
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91.3%, China 91.9%, and UK 90.1%. The standard deviation
in the sensitivity values across the six countries was 1.3%.
The specificities, defined as to the proportion of patients
classified as not having microaneurysms by human graders
that were correctly identified as such by the automated
system, were Kenya 82.7%, Botswana 83.2%, Norway 81.3%,
Mongolia 82.5%, China 83.0%, and UK 79.0%. The standard
deviation in the specificity values across the six countries was
1.5%.
The positive predictive values were Kenya 87%, Botswana
87%, Norway 82%, Mongolia 66%, China 67%, and UK 79%.
The negative predictive values were Kenya 90%, Botswana
87%, Norway 93%, Mongolia 96%, China 97%, and UK 90%.
4. Discussion
The prevalence of diabetes is increasing worldwide due
to population growth and increasing rates of obesity and
physical inactivity. Projections suggest that the prevalence of
diabetes in the USA will rise from 14% (in 2010) to between
25% and 28% by 2050 [12] and the worldwide prevalence
will rise from 2.8% (in 2000) to 4.4% by 2030, with an
expected worldwide population of 366 million people with
diabetes.Themost significant increase over the three decades
is expected to involve the Middle East (+163%), Sub-Saharan
Africa (+161%), China (+104%), and India (+151%) [17]. 2011
census data shows a rise in the English andWelsh population
of people ofmiddle eastern, Sub-Saharan African, and Indian
origin, whichmay further accelerate the rise in the prevalence
of diabetes in the UK [18].
DR screening programmes have been recognized as
an effective method for disease detection at the earliest
stage of the disease to potentially prevent permanent visual
loss. However, due to a rapidly expanding population of
patients with diabetes, the screening programme will require
significant annual increases in investment, along with the
recruitment and training of an increasing number of qualified
human graders. In order to alleviate this problem, several
attempts have been made to develop an automated system to
assist human graders [19].
The specificity of our automated system remained con-
sistent across all the racial groups examined with standard
deviation of only 1.3% and results ranging from 83.2% in
Botswana to 81.3% in Norway confirming its ability to
accurately detect normal images irrespective of the race of the
patient. Its sensitivity ranged from 91.1% in Botswana and the
UK to 93.5% in Norway, with a standard deviation of 1.5%,
demonstrating that it does not miss DR in the vast majority
of cases and was again consistent across the different racial
groups studied. In some cases, DR that was missed by human
graders was detected by the system. In such cases a human
grader reevaluated the images.
The standardised negative predictive value of the system
was highly consistent across all countries varying from 87%
in Botswana to 97% in China, suggesting that negative results
(no MAs) are highly likely to be accurate. Conversely the
positive predictive value ranged between 66% in Mongolia
and 87% in Kenya and Botswana, suggesting that positive
results (presence of MAs) would require further human
grading.Thus, the value of this system lies chiefly in its ability
to rapidly and reliably identify the absence of MAs, a task
whichmay take a human gradermuch longer than identifying
MAs when they are present. Given that the majority of
patients attending screening do not have DR, the use of such
a system has the potential to vastly reduce the number of
images requiring human grading.
One key limitation in this study is that the performance
of the system was evaluated only relative to human grading
of the same images rather than additional modalities such as
other automated systems or FFA.Therefore, it is only possible
to conclude that the system tends to give very similar results
to humans when grading DFIs without retinopathy across a
wide range of racial groups. It cannot account for any possible
systematic errors in grading if humans are also susceptible to
those same mistakes. In addition, although the system was
built to detect microaneurysms, it is impossible to compare
which exact MAs the automated system detected compared
to humans.
The previously reported structural and anatomical retinal
differences amongst different racial groups includingmacular
pigment distribution [10], the presence of the parafoveal ring,
and the retinal microvascular calibre variation [7, 8] along
with clinically visible differences in pigmentation do not
appear to have impacted significantly on the performance
of this automated system, which performed well across a
wide range of different racial groups. This represents a
significant advantage of the Daphne system that has not
been specifically tested for in previous automated systems.
Similarly, differences in image quality and illumination have
not had a significant effect on the automated detection of DR.
5. Conclusions
The data presented here suggests the possible scalability of an
automated microaneurysm detection platform that enables
rapid identification of patients without DR across a wide
range of races.
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